• CVS Health Tinkers, Teladoc Totters, Moderna Tanks
    Oct 20 2024

    A dinosaur in a fur coat is not a mammal

    Show more Show less
    8 mins
  • On the "Perverse Rebate System" in the Drug Market
    Oct 18 2024

    The current economics of the drug market have stopped making sense

    Show more Show less
    8 mins
  • How to Save UnitedHealthcare from Strategic Collapse
    Oct 17 2024

    As a general rule, you can’t “fix” an embedded economic system, whether that economic system orbits around Starbucks, Nike, UnitedHealthcare or the U.S. Congress

    Show more Show less
    7 mins
  • Should JNJ Acquire Walgreens?
    Oct 15 2024

    The pharmaceutical industry needs a new strategic model for success.

    Show more Show less
    9 mins
  • Missing from Starboard's "Extensive Slide Deck" to Turn Around Pfizer
    Oct 10 2024

    Cost-cutting logic is devouring the pharmaceutical industry. The new “turnaround skill” is market innovation.

    Show more Show less
    13 mins
  • Re: CVS Health Exploring a Break Up
    Oct 1 2024

    The traditional "business model" approach, which focuses on operational efficiency, is failing to address the deeper need for bigger ideas and smarter strategies. New growth curves (and job security) works with a different ‘turn-around skill’ altogether.

    Show more Show less
    10 mins
  • The "Strategic Direction" Thing
    Sep 30 2024

    Shareholder value is not just about business performance. It’s also about story performance.

    Show more Show less
    9 mins
  • Why the Pharmaceutical Industry Needs to Think Like Quentin Tarantino
    Sep 17 2024

    Uses Quentin Tarantino's filmmaking style as a metaphor to illustrate how the pharmaceutical industry needs to move away from outdated, formulaic strategies and embrace a more creative, character-driven approach. When it comes to commercial model innovation, drug companies must rethink their storytelling by creating unique, original narratives.

    Show more Show less
    9 mins